REGULATORY ASPECTS OF SAFETY REPORT IN PHARMACEUTICALS

Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 1

Abstract

In pharmaceutical industry it is essential to evaluate safety profile of pharmaceutical products during drug development and after marketing authorization. Regulatory agencies are very stringent to give marketing authorization of investigational drug for public health. That’s why regulatory agencies implement new rules for safety report. Safety report provides concise information on safety of drug. In pharmaceutical industry there are two types of safety report, Expedited safety report and aggregated safety reports. ICH provides a harmonized format for safety report to regulatory agencies that includes Expedited safety report for preclinical and post marketing safety studies, Periodic benefit and risk evaluation report (PBRER) aggregated report for marketing authorized drug and development safety update report (DSUR) aggregated report for drugs under clinical trial.

Authors and Affiliations

Dr. Dilip G. Maheshwari

Keywords

Related Articles

TO CREATE AWARENESS AMONG THE PEOPLE ABOUT ILL EFFECTS OF FREQUENT USE OF MEDICATION

Objective: The main objective of this article is to create awareness among the people of modern world about ill effects of frequent use of medication. Summary: The frequent intake of drugs in the form of medications may...

PHARMACEUTICAL ACTIVITY OF 1,3,4-OXADAIZOLE IN HETEROCYCLIC CHEMISTRY. A REVIEW

Oxadiazole and its derivatives have been focused on for their broadly chemical and biological importance in a previous couple of years. In this review, the Different Synthesis and its biological activities of 1,3,4-Oxadi...

ANALYTICAL STUDY ON ASTHIVAHA SROTAS & ITS APPLIED ASPECT

“Dosha Dhatu Mala Mulam Hi shariram” which means that Vataadi Tridosha, Rasadi Sapta Dhatu & Trimala (Mutra, Purish, Sweda) are the building blocks of human body. For a healthy body each individual should have Sama Prama...

ICSI OUTCOME AFTER USE OF DURIAN FOR INFERTILE MALE

Background: In vitro fertilization (IVF) cycle outcome correlates with the severity of seminal fluid analysis abnormalities as well as maternal age, number of follicles picked up and endometrial condition at time of embr...

NODDING SYNDROME IN NORTHERN UGANDA; TREATMENT AND REHABILITATION OUTCOMES: A LONGITUDINAL STUDY DESIGN

Background: Nodding Syndrome (NS) is an emerging neurological disorder in East Africa that affects children that are subject to civil disruption, internal displacement, food insecurity, malnutrition and nematode infectio...

Download PDF file
  • EP ID EP619147
  • DOI -
  • Views 106
  • Downloads 0

How To Cite

Dr. Dilip G. Maheshwari (2018). REGULATORY ASPECTS OF SAFETY REPORT IN PHARMACEUTICALS. World Journal of Pharmaceutical Research, 7(1), 279-289. https://europub.co.uk/articles/-A-619147